Skip to main content

Table 1 Baseline characteristics and operative characteristics

From: Survival and quality of life after surgical aortic valve replacement in octogenarians

  

Age < 80

Age ≥ 80

 
  

N = 597

N = 163

P

Male sex

363 (60.8)

85 (52.1)

0.057

Age, years

71 (66–75)

82 (81–83)

<0.001

History of:

   

 DM

145 (24.4)

37 (22.7)

0.727

 Hypertension

325 (54.4)

98 (60.1)

0.228

 COPD

116 (19.4)

30 (18.4)

0.855

 Peripheral VD

70 (11.7)

17 (10.4)

0.748

 Stroke

66 (11.1)

20 (12.3)

0.768

 MI

74 (12.4)

21 (12.9)

0.979

 PCI

65 (10.9)

18 (11.0)

1.000

 Cardiac surgery

42 (7.0)

8 (4.9)

0.428

Creatinine (mmol/L)

88 (75–104)

92 (77–110)

0.001

EuroSCORE

6 (5–7)

8 (8–10)

<0.001

Log EuroSCORE

4.9 (3.1–7.6)

10.7 (8.4–15.7)

<0.001

LVEF

>50 %

468 (78.7)

113 (69.3)

0.044

 

30–50 %

103 (17.3)

40 (24.5)

 
 

<30 %

24 (4.0)

10 (6.1)

 

NYHA

Class 1

145 (24.3)

45 (27.6)

0.149

 

Class 2

342 (57.4)

80 (49.1)

 
 

Class 3

109 (18.3)

38 (23.3)

 

Peak gradient AV (mmHg)

73 (60–90)

71 (58–88)

0.55

Operative characteristics

   

 Bioprosthesis

541 (90.6)

159 (97.6)

<0.001

 CABG

298 (49.9)

75 (46.0)

0.426

 X-clamp time (min)

91 (75–111)

82 (68–107)

0.004

  1. Baseline chararcteristics and operative characteristics in octogenarians and patients aged less than 80 years. Values are number (%), continuous variables are presented as median (25th–75th percentile)
  2. DM diabetes mellitus, COPD chronic obstructive pulmonary disease, VD vascular disease, MI myocardial infarction, PCI percutanaeous coronary intervention, LVEF left ventricular ejection fraction, NYHA New York Heart Association, AV aortic valve, peak gradient = maximum gradient over the aortic valve, CABG coronary artery bypass grafting